Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An External Control, Observational, Retrospective Study Assessing the Effect of Avapritinib Compared With Best Available Therapy for Patients With Advanced Systemic Mastocytosis

NCT04695431 is registered in ClinicalTrials.gov with Blueprint Medicines Corporation as lead sponsor.

NCT NCT04695431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04695431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An External Control, Observational, Retrospective Study Assessing the Effect of Avapritinib Compared With Best Available Therapy for Patients With Advanced Systemic Mastocytosis
Lead sponsor
Blueprint Medicines Corporation
Phase
Observational
Overall status
Completed
Start date
December 2, 2020
Completion date
October 4, 2021
Enrollment
317 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced systemic mastocytosis, aggressive systemic mastocytosis, mast cell leukemia, systemic mastocytosis with an associated hematological neoplasm